BioCentury
ARTICLE | Clinical News

CoMMpass study allows real-time patient decisions

June 21, 2016 12:38 AM UTC

On Monday, the Multiple Myeloma Research Foundation (MMRF) said the patient-led and conceived CoMMpass study has been amended to allow physicians to use genomic data from participating patients to make real-time treatment decisions.

CoMMpass is a sequencing study that is following more than 1,000 multiple myeloma patients to determine how molecular profiles change with response and retreatment (see BioCentury, Dec. 14, 2015). ...